Clinical Trial Update: Worms for Immune Regulation of Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating helminth-based immunomodulation for relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Helminth therapy

Snippet

Sponsor: University of Nottingham | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED